Search Results 711-720 of 14699 for anti-TNF drugs

1. Sulfamethoxazole/Trimethoprim (Intravenous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. Descriptions. Sulfamethoxazole and trimethoprim combination is used to ...

2. Tafamidis (Oral Route) Precautions - Mayo Clinic

   Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant during treatment ...

3. CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies - Mayo Clinic

   The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...

4. Typhoid Vaccine (Intramuscular Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

5. Lamotrigine (Oral Route) Proper Use - Mayo Clinic

   Keep using all of your seizure medicines unless your doctor tells you to stop. Dosing. The dose of this medicine will be different for different patients.

6. Pneumococcal Vaccine Polyvalent (Intramuscular Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Pneumovax 23; Pnu-Imune 23. Canadian ...

7. Pentazocine And Naloxone (Oral Route) Description and Brand Names - Mayo Clinic

   Pentazocine and naloxone combination is used to relieve pain severe enough to require opioid treatment and when other pain medicines did not work well enough or ...

8. Ustekinumab (Injection Route) Precautions - Mayo Clinic

   Tell your doctor if you have a latex allergy before you start receiving this medicine. While you are being treated with ustekinumab and after you stop treatment ...

9. Ofatumumab (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

   This medicine is also used in patients with CLL who have already been treated with other medicines (eg, alemtuzumab, fludarabine) that did not work well.

10. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

    ... TNF] agents) within 4 weeks prior to cycle 1, day ... drugs); replacement therapy ... A stable regimen of highly active anti-retroviral therapy (HAART) ...